NCT01737645
Terminated
Not Applicable
A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients
ConditionsIntraocular Pressure Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intraocular Pressure Disorder
- Sponsor
- William Beaumont Hospitals
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.
- Status
- Terminated
- Last Updated
- 11 years ago
Overview
Brief Summary
This study is to determine if there is a rise in eye pressure, when patients are placed in a position where the head is lower than the rest of the body during long surgeries.
Detailed Description
Eye pressure will be measured at protocol specified intervals.
Investigators
Roy Soto, MD
Principal Investigator
William Beaumont Hospitals
Eligibility Criteria
Inclusion Criteria
- •Subjects undergoing prolonged procedures (scheduled \>3hr) in steep Trendelenburg position (eg. robotic prostatectomy, hysterectomy, cystectomy)
- •Morbidly obese subjects: BMI ≥ 35 kg/m2
- •Thin subjects: BMI ≤ 30 kg/m2
- •ASA (American Society of Anesthesiologists) physical status classification I, II, or III
Exclusion Criteria
- •Known history of glaucoma
- •Note:if initial IOP is noted to be \>21mmHg (millimeters of mercury), patient will be excluded from study and an ophthalmology consultation will be obtained.Surgery will not be postponed.
- •Recent use of IOP lowering topical ophthalmic agents
- •Allergy to latex or proparacaine hydrochloride ophthalmic solution
- •Patients with active corneal epithelial defects or history of recurrent corneal erosion
- •Patients with underlying disorders that can directly increase intraocular pressure (thyroid eye disease, intra orbital tumors, orbital vascular malformation, Sturge-Weber disease, carotid or dural cavernous arteriovenous malformation, cavernous sinus pathology)
- •History of corneal surgery, to include LASIK (laser-assisted in-situ keratomileusis)
- •Any eye surgery within prior 1 month
- •Known pregnancy
- •Cognitive impairment
Outcomes
Primary Outcomes
To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.
Time Frame: Measured from baseline IOP to peak IOP during steep Trendelenburg. The overall time frame for which the outcome measure is assessed is up to 3 years.
Secondary Outcomes
- To determine rate of rise of IOP during steep Trendelenburg positioning(The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.)
- To compare peak IOP and rise of IOP during steep Trendelenburg positioning in thin vs morbidly obese subjects.(The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
IOP Device Comparison StudyIntraocular PressureNCT04211792Lawson Health Research Institute101
Recruiting
Not Applicable
TO COMPARE THE PRESSURE INSIDE THE EYE USING TWO INSTRUMENTS IN PATIENTS HAVING WEAK CORNEA WHO ARE UNDERGOING A CORRECTIVE PROCEDUREHealth Condition 1: null- PATIENTS HAVING KERATOCONUS UNDERGOING CORNEAL COLLAGEN CROSSLINKING WITH RIBOFLAVICTRI/2015/06/005839ETHRADHAMA SUPER SPECIALITY EYE HOSPITA50
Completed
Not Applicable
The Intraocular Pressure Measured by Different Tonometers in Corneal EdemaIntraocular PressureCorneal EdemaNCT01998568Prince of Songkla University50
Completed
Not Applicable
SENSIMED Triggerfish® in Sitting and Supine PositionHealthy SubjectsNCT01347229Sensimed AG20
Terminated
Not Applicable
Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by UltrasoundUrological CancerGastrointestinal CancerMalignant Female Reproductive System NeoplasmNCT02818530Tata Memorial Centre10